Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2). [electronic resource]
Producer: 20110812Description: 57-68 p. digitalISSN:- 1471-4159
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine -- pharmacology
- ADAM Proteins -- metabolism
- Animals
- Animals, Newborn
- Botulinum Toxins, Type A -- pharmacology
- Cell Membrane -- physiology
- Cells, Cultured
- Chelating Agents -- pharmacology
- Coculture Techniques
- Corpus Striatum -- cytology
- Dopamine -- metabolism
- Dopamine Agonists -- pharmacology
- Embryo, Mammalian
- Enzyme Inhibitors -- pharmacology
- Enzyme-Linked Immunosorbent Assay -- methods
- Epidermal Growth Factor -- metabolism
- ErbB Receptors -- metabolism
- Gangliosides -- metabolism
- Matrix Metalloproteinases -- metabolism
- Models, Biological
- Nerve Tissue Proteins -- metabolism
- Neuroglia -- physiology
- Neurons -- cytology
- Neurotoxins -- pharmacology
- Quinpirole -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Receptors, Dopamine -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.